33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes of patients with resectable pancreatic cancer treated with upfront surgery versus neoadjuvant chemotherapy: A retrospective tertiary care center experience
    Meeting Abstract

    Liu, F.; Mirsky, M.; Wu, S.; Fu, P.; Cao, S.; Shanahan, J.; Kyasaram, R. K.; Jain, P.; Hardacre, J.; Ammori, J. B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • DREAMM-2: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) and renal impairment
    Meeting Abstract

    Lee, H. C.; Cohen, A. D.; Chari, A.; Hultcrantz, M.; Nooka, A. K.; Callander, N. S.; Suvannasankha, A.; Badros, A.; Libby, E. N.; Trudel, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase Ib study to evaluate the oral selective estrogen receptor degrader GDC-9545 alone or combined with palbociclib in metastatic ER-positive HER2-negative breast cancer
    Meeting Abstract

    Lim, E.; Jhaveri, K. L.; Perez-Fidalgo, J. A.; Bellet, M.; Boni, V.; Garcia, J. M. P.; Estevez, L.; Bardia, A.; Turner, N. C.; Villanueva, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for disease progression after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell renal cell carcinoma (mccRCC)
    Meeting Abstract

    Lee, C. H.; Shah, A. Y.; Hsieh, J. J.; Rao, A.; Pinto, A.; Bilen, M. A.; Cohn, A. L.; Di Simone, C.; Shaffer, D. R.; Sarrio, R. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid tumors with activating HER2 alterations: A phase I basket trial
    Meeting Abstract

    Li, B. T.; Li, T.; Johnson, M. L.; Waqar, S. N.; Zhu, V. W.; Ou, S. H. I.; Lin, J. J.; Wang, D.; Shapiro, G.; Wang, J. S. Z.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Primary efficacy and biomarker analyses from the VISION study of tepotinib in patients (pts) with non-small cell lung cancer (NSCLC) with METex14 skipping
    Meeting Abstract

    Le, X.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A. B.; Garassino, M. C.; Mazieres, J.; Ramirez, S. V.; Senellart, H.; Van Meerbeeck, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicity (Q-TWiST) of lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Lee, C. H.; Wan, Y.; Smith, A. D.; Xie, R.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Changes in cancer mortality rates after the adoption of the Affordable Care Act
    Meeting Abstract

    Lee, A.; Shah, K.; Chino, J. P.; Chino, F.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Nickel and dimed: Parking fees at NCI-designated cancer centers
    Meeting Abstract

    Lee, A.; Shah, K.; Byun, J.; Chino, F.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Brannon, A. R.; Zehir, A.; Arcila, M. E.; Benayed, R.; Chaft, J. E.; Drilon, A. E.; Kris, M. G.; Gomez, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save